Vical Competitors and Similar CompaniesClear all
Vical's competitors and similar companies include Cure Genetics, Zyngenia, Amgen and Cytura Therapeutics.
 Vical Vical is a company that researches and develops biopharmaceutical products based on its patented DNA delivery technologies. |  Cure Genetics Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases. |  Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Cytura Therapeutics Cytura Therapeutics is a pharmaceutical company aiming to find a solution to stop the destabilization of the genome. | |
Founding Date | Founding Date 1987 | Founding Date 2016 | Founding Date 2009 | Founding Date 1980 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations HQ | Locations Washington, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Oss, NL HQ |
Employees | Employees 3059% decrease | Employees 15 | Employees N/A | Employees 25,200 | Employees 1 |
Valuation ($) | Valuation ($) 16.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $404k (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($39.5m) (FY, 2021) | Net income N/A | Net income N/A | Net income $7.7b (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 9.5m (about 6 years ago) | Latest funding round $ 25m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 26.5m | Total funding raised $ 25m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Cure Genetics
HQ
Employees
15
Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases.
View companyZyngenia
HQ
Washington, US
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyCytura Therapeutics
HQ
Oss, NL
Employees
1
Cytura Therapeutics is a pharmaceutical company aiming to find a solution to stop the destabilization of the genome.
View company